CN105597083B - A kind of pair of liver kidney has health food of auxiliary protection function and preparation method thereof - Google Patents
A kind of pair of liver kidney has health food of auxiliary protection function and preparation method thereof Download PDFInfo
- Publication number
- CN105597083B CN105597083B CN201610068849.1A CN201610068849A CN105597083B CN 105597083 B CN105597083 B CN 105597083B CN 201610068849 A CN201610068849 A CN 201610068849A CN 105597083 B CN105597083 B CN 105597083B
- Authority
- CN
- China
- Prior art keywords
- parts
- health food
- added
- raw material
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013402 health food Nutrition 0.000 title claims abstract description 65
- 210000004185 liver Anatomy 0.000 title claims abstract description 61
- 210000003734 kidney Anatomy 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 239000002994 raw material Substances 0.000 claims abstract description 42
- 239000012141 concentrate Substances 0.000 claims abstract description 41
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 37
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 37
- 240000000759 Lepidium meyenii Species 0.000 claims abstract description 34
- 235000000421 Lepidium meyenii Nutrition 0.000 claims abstract description 34
- 235000012902 lepidium meyenii Nutrition 0.000 claims abstract description 34
- 239000000843 powder Substances 0.000 claims abstract description 33
- 244000179886 Moringa oleifera Species 0.000 claims abstract description 32
- 235000011347 Moringa oleifera Nutrition 0.000 claims abstract description 32
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 31
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 31
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 31
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 31
- 235000021119 whey protein Nutrition 0.000 claims abstract description 31
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 29
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 29
- 241000190633 Cordyceps Species 0.000 claims abstract description 28
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims abstract description 27
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims abstract description 27
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims abstract description 27
- 235000012661 lycopene Nutrition 0.000 claims abstract description 27
- 229960004999 lycopene Drugs 0.000 claims abstract description 27
- 239000001751 lycopene Substances 0.000 claims abstract description 27
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims abstract description 27
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims abstract description 26
- 239000000203 mixture Substances 0.000 claims abstract description 22
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 21
- 235000019710 soybean protein Nutrition 0.000 claims abstract description 21
- 235000013305 food Nutrition 0.000 claims abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 125
- 235000019441 ethanol Nutrition 0.000 claims description 74
- 239000000706 filtrate Substances 0.000 claims description 34
- 239000006071 cream Substances 0.000 claims description 32
- 239000008187 granular material Substances 0.000 claims description 23
- 238000001914 filtration Methods 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 15
- 239000000284 extract Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- 239000004615 ingredient Substances 0.000 claims description 13
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 12
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 12
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 12
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 12
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 10
- 235000018102 proteins Nutrition 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- 238000004064 recycling Methods 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 238000010992 reflux Methods 0.000 claims description 8
- 244000068988 Glycine max Species 0.000 claims description 7
- 235000010469 Glycine max Nutrition 0.000 claims description 7
- 240000003768 Solanum lycopersicum Species 0.000 claims description 7
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 6
- 235000019359 magnesium stearate Nutrition 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 239000001054 red pigment Substances 0.000 claims description 4
- 239000003643 water by type Substances 0.000 claims description 4
- 235000015091 medicinal tea Nutrition 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 29
- 230000036039 immunity Effects 0.000 abstract description 6
- 239000003963 antioxidant agent Substances 0.000 abstract description 5
- 230000003078 antioxidant effect Effects 0.000 abstract description 5
- 235000006708 antioxidants Nutrition 0.000 abstract description 5
- 230000002265 prevention Effects 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 3
- 230000003712 anti-aging effect Effects 0.000 abstract description 2
- 238000012545 processing Methods 0.000 abstract description 2
- 230000006870 function Effects 0.000 description 33
- 241000700159 Rattus Species 0.000 description 30
- 231100000753 hepatic injury Toxicity 0.000 description 24
- 206010067125 Liver injury Diseases 0.000 description 20
- 230000001476 alcoholic effect Effects 0.000 description 17
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 16
- 210000001519 tissue Anatomy 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 230000002440 hepatic effect Effects 0.000 description 14
- 230000006378 damage Effects 0.000 description 13
- 239000003814 drug Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 239000000523 sample Substances 0.000 description 12
- 230000036541 health Effects 0.000 description 9
- 229960003180 glutathione Drugs 0.000 description 8
- 231100000240 steatosis hepatitis Toxicity 0.000 description 8
- 150000003626 triacylglycerols Chemical class 0.000 description 8
- 239000005913 Maltodextrin Substances 0.000 description 7
- 229920002774 Maltodextrin Polymers 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 210000005228 liver tissue Anatomy 0.000 description 7
- 229940035034 maltodextrin Drugs 0.000 description 7
- 239000011122 softwood Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 206010013786 Dry skin Diseases 0.000 description 6
- 230000007863 steatosis Effects 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- -1 health care Substances 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 239000013642 negative control Substances 0.000 description 5
- 238000009423 ventilation Methods 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 208000019423 liver disease Diseases 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010019799 Hepatitis viral Diseases 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 108090000340 Transaminases Proteins 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 208000019425 cirrhosis of liver Diseases 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 239000013068 control sample Substances 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 239000000469 ethanolic extract Substances 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 231100000234 hepatic damage Toxicity 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000003907 kidney function Effects 0.000 description 3
- 239000006101 laboratory sample Substances 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000008818 liver damage Effects 0.000 description 3
- 206010036067 polydipsia Diseases 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 102000014898 transaminase activity proteins Human genes 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 2
- 240000001307 Myosotis scorpioides Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 208000001647 Renal Insufficiency Diseases 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000007674 genetic toxicity Effects 0.000 description 2
- 231100000025 genetic toxicology Toxicity 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000009758 senescence Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 244000201986 Cassia tora Species 0.000 description 1
- 235000014552 Cassia tora Nutrition 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010009208 Cirrhosis alcoholic Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000220214 Moringaceae Species 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 101710089165 Protein white Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000009257 Visceral Prolapse Diseases 0.000 description 1
- 206010063840 Visceroptosis Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000002353 alcoholic hepatitis Diseases 0.000 description 1
- 208000010002 alcoholic liver cirrhosis Diseases 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000026781 habituation Effects 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000004789 organ system Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 231100001028 renal lesion Toxicity 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000020097 white wine Nutrition 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to the health foods and preparation method thereof that a kind of pair of liver kidney has auxiliary protection function, belong to food processing technology field.Its raw material of the health food includes ganoderma lucidum, Moringa, cassia seed, Maca, Fructus Corni, cordyceps mycelia powder, whey protein concentrate, soybean protein isolate, VA, VB1、VB2、VB6, xylo-oligosaccharide, lycopene, apple polyphenol.The health food passes through selection raw material meticulously, and scientific composition not only has the effect of auxiliary protection function to liver kidney, also has prevention " three high ", anti-oxidant, anti-aging, improves the health-care effects such as immunity.
Description
Technical field
The present invention relates to the health foods and preparation method thereof that a kind of pair of liver kidney has auxiliary protection function, belong to food processing
Technical field.
Background technique
China is hepatopathy big country, in recent years virus hepatitis, fatty liver, alcoholic liver disease, medicamentous liver lesion and liver cancer
Etc. hepatopathys have become threaten human health one of principal disease.And since living habit and social custom problem lead to some people
Long-term alcohol is even drunk beyond one's capacity, and alcohol has become the second largest killer of liver for being only second to virus hepatitis.In heavy drinker
80% or more has a degree of fatty liver, and 10%~35% can develop into alcoholic hepatitis, and 10%~20% will develop into liver
Hardening, and alcoholic cirrhosis prognosis is poor, survival rate is about 23~50% within 5 years.Investigation points out that China's alcoholic liver disease is in institute
There is the ratio in hepatopathy to have and increase trend year by year, but specific treatment medicine there is no to alcoholic liver disease at present.
The kidney being the origin of congenital constitution.When kidney deficiency, essence, gas, the yin, yang void of kidney decline deficiency, be easy to appear body is thin, spirit not
Vibration, soreness and weakness of waist and knees, dizzy tinnitus, insomnia and dreamful sleep, amnesia of sleeping less, spermatorrhea frequent micturition, hectic fever night sweat, dry or the cold limb cold of shape, asthma are inverse
Etc. symptoms, cause the immunocompetence of people to reduce.And the microcirculqtory system of kidney the problem of also blocking, i.e., kidney network can be presented
It is obstructed, it is the pathogenetic pathologic basis of kidney.Renal insufficiency is as caused by many reasons, and glomerulus seriously destroys, and makes body
Excretion metabolism waste and adjust Water-Electrolyte, in terms of the clinical syndrome that gets muddled after group.
Therefore, the health food that a kind of pair of liver kidney has auxiliary protection function is researched and developed, liver kidney damage is prevented by diet
Wound mitigates the symptom of hepatic and kidney function obstacle person, is very suitable to China's national situation and the needs of patient.Such health food market is also
Sizable development space.
Summary of the invention
In order to solve the above technical problems, it is an object of that present invention to provide the health care foods that a kind of pair of liver kidney has auxiliary protection function
Product and preparation method thereof.For the health food by selecting raw material meticulously, scientific composition not only has auxiliary protection function to liver kidney
Effect also has prevention " three high " (referring to hypertension, hyperglycemia (diabetes) and hyperlipidemia), anti-oxidant, anti-aging, improves
The health-care effects such as immunity.
Realize that the object of the invention technical solution is as follows:
A kind of pair of liver kidney has the health food of auxiliary protection function, and raw material includes ganoderma lucidum, Moringa, cassia seed, Maca, mountain
The fruit of medicinal cornel, cordyceps mycelia powder, whey protein concentrate, soybean protein isolate, VA, VB1、VB2、VB6, xylo-oligosaccharide, lycopene,
Apple polyphenol.
Preferably, its raw material includes 10-200 parts of ganoderma lucidum, 10-150 parts of Moringa, Cassia to the health food in parts by weight
It is 5-50 parts sub-, Maca 10-150 parts, it is 10-200 parts of Fructus Corni, 5-50 parts of cordyceps mycelia powder, 5-50 parts of whey protein concentrate, big
5-50 parts of beans protein isolate, 0.0001-0.0005 parts of VA, VB10.0005-0.005 parts, VB20.0005-0.005 parts, VB6
0.0005-0.005 parts, 0.1-5 parts of xylo-oligosaccharide, 0.01-0.1 parts of lycopene, 0.01-0.1 parts of apple polyphenol.
It is further preferred that its raw material includes 50-150 parts of ganoderma lucidum, Moringa 20-100 to the health food in parts by weight
Part, 10-40 parts of cassia seed, Maca 20-100 parts, 50-150 parts of Fructus Corni, 10-40 parts of cordyceps mycelia powder, whey protein concentrate
10-40 parts, 10-40 parts of soybean protein isolate, 0.0001-0.0005 parts of VA, VB10.001-0.005 parts, VB2 0.001-
0.005 part, VB60.001-0.005 parts, 1-5 parts of xylo-oligosaccharide, 0.02-0.08 parts of lycopene, apple polyphenol 0.02-0.08
Part.
Preferably, the health food in parts by weight its raw material include 120 parts of ganoderma lucidum, 80 parts of Moringa, 15 parts of cassia seed,
35 parts of Maca, 70 parts of Fructus Corni, 20 parts of cordyceps mycelia powder, 15 parts of whey protein concentrate, 25 parts of soybean protein isolate, VA
0.0003 part, VB10.002 part, VB20.003 part, VB60.002 part, 3 parts of xylo-oligosaccharide, 0.05 part of lycopene, apple it is more
0.03 part of phenol.
In above-mentioned health food, it is preferable that the protein content in the whey protein concentrate is >=80% (with dry weight
Meter)；Protein content >=99% in soybean protein isolate；Lycopene content >=10% in lycopene；Apple polyphenol
In apple polyphenol content >=50%.
The parts by weight can be the unit of weight well known in the art such as μ g, mg, g, kg, be also possible to its multiple, and such as 1/
10,1/100,10 times, 100 times etc..
The above-mentioned health food for having auxiliary protection function to liver kidney, wherein ganoderma lucidum, Moringa, cassia seed, Maca, Fructus Corni,
Cordyceps mycelia powder, whey protein concentrate, soybean protein isolate, VA, VB1、VB2、VB6, xylo-oligosaccharide, lycopene, apple it is more
Phenol is as active raw materials；Preferably, its raw material of above-mentioned health food or auxiliary material further include pharmaceutically or on food or health care
Acceptable carrier on food.
Preferably, the health food is formed into oral preparation；It include: capsule, granule, tablet, packed medicinal tea, powder
Agent etc.；More preferably granule.
It is further preferred that its raw material of the health food or auxiliary material further include microcrystalline cellulose, magnesium stearate.
The present invention also provides the preparation methods of above-mentioned health food, method includes the following steps: weighing according to the proportion each
Ingredient mixes, is prepared into preparation according to conventional preparation method.
Preferably, above-mentioned health food preparation method the following steps are included:
1) ingredient；Required raw material (including ganoderma lucidum, Moringa, cassia seed, Maca, Fructus Corni, Chinese caterpillar fungus hypha are weighed according to the ratio
Body powder, whey protein concentrate, soybean protein isolate, VA, VB1、VB2、VB6, xylo-oligosaccharide, lycopene, apple polyphenol etc.)；
2) after mixing ganoderma lucidum, Moringa, cassia seed, Maca, Fructus Corni, the 50%-90% ethyl alcohol of 5-10 times of weight is added to return
Stream extracts 1-3 times, 0.5-3.0 hours each, filtration, and filter residue is spare；Merging filtrate concentrates the filtrate to clear cream (relative density
For 1.10-1.30,30 DEG C), ethyl alcohol, which is added, makes alcohol content up to 70%-75%, obtains solution I；
3) water of 5-15 times of weight is added to decoct 1-3 times filter residue obtained by step 2), 0.5-2 hours each, collecting decoction, filter
It crosses, concentrates the filtrate to clear cream (relative density 1.10-1.30,30 DEG C), add ethyl alcohol to make alcohol content up to 70%-75%, obtain molten
Liquid II；
4) merge the solution I and solution II, stir evenly, stand, it is (relatively close to be concentrated into clear cream for filtration, filtrate recycling ethanol
Spending is 1.10-1.30,30 DEG C)；Remaining raw material (cordyceps mycelia powder, whey protein concentrate, soybean separation protein is added by formula
White, VA, VB1、VB2、VB6, xylo-oligosaccharide, lycopene, apple polyphenol etc.) and appropriate amount of auxiliary materials suitable dosage form is made.It is preferred that
Ground is added appropriate amount of auxiliary materials microcrystalline cellulose, magnesium stearate, granule is made.
Specifically, above-mentioned health food preparation method the following steps are included:
1) ingredient；Required raw material (including ganoderma lucidum, Moringa, cassia seed, Maca, Fructus Corni, Chinese caterpillar fungus hypha are weighed according to the ratio
Body powder, whey protein concentrate, soybean protein isolate, VA, VB1、VB2、VB6, xylo-oligosaccharide, lycopene, apple polyphenol etc.)；
2) by ganoderma lucidum, Moringa, cassia seed, Maca, Fructus Corni mix after, with 70%-75% alcohol reflux extract 2 times, the 1st
Secondary that 8 times of w ethanols extraction 3h are added, 6 times of w ethanols of the 2nd addition extract 1h, filter, filter residue is spare；Merging filtrate, will
Filtrate is concentrated into clear cream (relative density 1.10-1.30,30 DEG C), and ethyl alcohol, which is added, makes alcohol content up to 70%-75%, obtains solution I；
3) filter residue obtained by step 2) is added water to cook 2 times, 10 times of weight waters of the 1st addition decoct 2h, the 2nd 8 times of addition
W ethanol extracts 1h, collecting decoction, and filtration concentrates the filtrate to clear cream (relative density 1.10-1.30,30 DEG C), adds second
Alcohol makes alcohol content up to 70%-75%, obtains solution II；
4) merge the solution I and solution II, stir evenly, stand, it is (relatively close to be concentrated into clear cream for filtration, filtrate recycling ethanol
Spending is 1.10-1.30,30 DEG C)；Remaining raw material (cordyceps mycelia powder, whey protein concentrate, soybean separation protein is added by formula
White, VA, VB1、VB2、VB6, xylo-oligosaccharide, lycopene, apple polyphenol etc.) and appropriate amount of auxiliary materials suitable dosage form is made.It is preferred that
Ground is added appropriate amount of auxiliary materials microcrystalline cellulose, magnesium stearate, granule is made.
Unless otherwise specified, concentration of alcohol of the present invention refers both to volumetric concentration.
It is demonstrated experimentally that the present invention extracts traditional Chinese medicinal material raw materials using above-mentioned technique, Chinese medicine original is utmostly remained
The effective ingredient of material, and the effective component extracted is easiest to be absorbed by the body, and enhances the absorption of drug, so as to avoid invalid
Ingredient interferes the problem of drug effect.
Ganoderma lucidum is mild-natured, bitter, nontoxic, and master ties in the heart, invigorating heart gas, bowl spares, increases wisdom, does not forget, and long term usage is made light of one's life by commiting suicide not always, macrobiosis
Angle.Ganoderma lucidum has protective effect to hepatic injury caused by a variety of physical and chemical and biological factors.No matter liver damage occur before or
After generation, liver can all be protected by taking ganoderma lucidum, mitigate hepatic injury.Ganoderma lucidum can promote metabolism of the liver to drug, poisonous substance, in
Virus hepatitis has exact curative effect.Especially chronic hepatitis, ganoderma lucidum can obviously eliminate the diseases such as dizzy, out of strength, nauseous, uncomfortable liver area
Shape, and liver function can be effectively improved, so that indices is tended to be normal.Ganoderma lucidum can be used for treating slow poisoning, all kinds of Chronic Livers
Inflammation, cirrhosis, hepatosis.Ganoderma lucidum kidney tonifying, strengthening the essence, wind-dispelling；It is adjustable immune function, improves body major organ systems,
Such as function of the heart, lung, liver, kidney.Studies have shown that ganoderma lucidum can promote the nucleic acid of serum, liver and marrow and the biology of protein
Synthesis has good kidney tonifying effect.
Moringa (Moringa) is also known as drumstick tree (Drumstick tree), is Capparales Moringaceae, Moringa arbor.
Moringa of the present invention is preferably moringa seeds, i.e. the seed of Moringa tree, is had in fields such as food, medicine, health care, cosmetics
Good application value because be rich in seed oil of Moringa oleigera, reduce blood lipid, blood pressure, weight-reducing, adjust stomach, protect liver guard against
Wine, enhancing human immunity aspect all has significant curative effect.
Cassia seed is the dry mature seed of legume cassia or little cassia tora.Cassia seed bitter, sweet, salty, cold nature enters
Liver, kidney, large intestine channel；Constipation and hyperlipidemia, hypertension are treated in relax bowel and defecation, lipid-loweringing improving eyesight.It clears liver and improve vision, sharp water defaecation has slow
The effect of rushing down, reducing blood pressure and blood fat.
Maca (scientific name: Lepidium meyenii Walp), (Spanish: Maca).It mainly produces in South America peace the
This mountain range and Chinese yunnan Lijing are a kind of crucifers.Due to containing the nutrition there are many balanced and reasonable in Maca
And a variety of biologically active secondary metabolites, therefore, Maca has plurality kinds of health care and therapeutic efficiency and effect, tradition
On can be used for enhancing energy, improve fertility, treatment climacteric syndrome, rheumatism, depression, anemia, in addition, it also has
There is the effects of anticancer and anti-leukocythemia.
Fructus Corni nature and flavor are sour, puckery, slightly warm in nature.Channel tropism returns liver and kidney channel.Fructus Corni tonifies the liver and kidney；Astringing and avoiding visceroptosis；It can mend
The yin of liver kidney, and energy kidney-replenishing, are the panaceas of the tonifying both YIN and YANG of this medicine is mild simply.
Cordyceps sinensis is sweet in flavor warm-natured, protects lung kidney-nourishing, qi-restoratives damage, mends marrow, hemostasis and phlegm, only consumptive disease cough.Cordyceps sinensis can mitigate chronic
Renal lesions improve renal function, mitigate damage of the toxicant to kidney, have anti-renal failure effect.Cordyceps mycelia powder, also known as
Cordyceps sinensis powder, with cordyceps sinensis have the function of similar ingredient and.Cordyceps mycelia powder of the present invention is preferably aweto mycelium
Powder, can be by prior art preparation, also buyable commercial prod.
Lycopene is a kind of natural pigment contained in plant.It is primarily present in the ripening fruits of plant of Solanaceae tomato
In.It is most one of the powerful antioxidant being found in the plant of nature at present.Science proof, the intracorporal singlet oxygen of people
It is the arch-criminal for encroaching on human body self immune system with oxygen radical.The effect of lycopene removing free radical, outclass other
Carotenoid and vitamin E, singlet-oxygen quenching rate constant are 100 times of vitamin E.It can with effectively preventing because
Aging, various diseases caused by immunity degradation.
Whey protein concentrate of the present invention, soybean protein isolate, VA, VB1、VB2、VB6, xylo-oligosaccharide, lycopene,
The equal buyable commercial prod of the supplementary materials such as apple polyphenol.
The present invention is guidance with Chinese Traditional Medicine theory, meticulous from health angle in conjunction with modern medicine study routine
Raw material is selected, scientific composition reaches the health-care effect of auxiliary protection liver kidney, and also there is prevention " three high " (to refer to hypertension, hyperglycemia
(diabetes) and hyperlipidemia), it is anti-oxidant, delay senescence, improve the health-care effects such as immunity.The present invention focuses on human body entirety
Not only there is the health care of auxiliary protection liver kidney to imitate for conditioning and inherent conditioning, the healthy food products developed in conjunction with health
Fruit, additionally it is possible to promote the good health and a long life of human body.
The principles of formulating prescriptions of the present invention: being monarch with ganoderma lucidum, Fructus Corni, using cassia seed, Maca as minister, with Moringa, cordyceps mycelia
Powder is assistant, is to make with lycopene, apple polyphenol, cooperates whey protein concentrate, soybean protein isolate, VA, VB1、VB2、VB6, it is low
Xylan improves product protection liver kidney function effect with collaboration.All medicines share, long memorial liver protects kidney, relieve stagnation analgesic altogether, and protecting liver, lowering enzymes reconcile
The effect of qi and blood, property of the present invention is peaceful, is conducive to long term usage, no adverse side effect.
Selected raw material of the present invention improves human five internal organs, and comprehensive function reaches the health-care effect of protection liver kidney.Wherein pass through tune
Reason heart keeps the motive vigorous, and painstaking effort are full；Liver storing blood keeps qi and blood gentle by improving liver, and blood operation is sufficient, red complexion
Moisten gloss；The spleen being the foundation of acquired constitution, source of generating QI and blood；By function of spleen and stomach regulating, make the strong fortune of its function, qi and blood is vigorous；Lung governing skin and hair,
Enable qi-blood-body fluid spreading whole body by improving lung；Kidney controlling essence storage keeps kidney essense full by conditioning kidney, when kidney qi is vigorous,
Function of five internal organs will also operate normally, and qi and blood is vigorous, and appearance does not wane.
Health food of the present invention is a kind of to follow the fashion, again take into account in a manner of traditional product drink, to reach in satisfied
It is beneficial to the purpose of person in middle and old age and sub-health population health care.Health food action temperature of the present invention and, efficacy stability is nontoxic secondary to make
With suitable long-term drinking.The study found that taking health food of the present invention for a long time also there is prevention " three high " (to refer to hypertension, high blood
Sugared (diabetes) and hyperlipidemia), it is anti-oxidant, delay senescence, improve the health-care effects such as immunity.
Specific embodiment
The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention..It is not specified in embodiment specific
Technology or conditions person, described technology or conditions according to the literature in the art, or carried out according to product description.It is used
Production firm person is not specified in reagent or instrument, is the conventional products that can be commercially available by regular distributor.Following embodiment
And in comparative example, whey protein concentrate purchased from inspiring confidence in (Tianjin) International Trading Company Ltd in day pool, protein content be 80% (with
Dry weight meter)；Soybean protein isolate is purchased from Shandong YuWang Industry Co., Ltd, protein content >=99%；Lycopene is purchased from west
Pacify Rayleigh Biotechnology Co., Ltd, lycopene content >=10%；Apple polyphenol is purchased from the biological Co., Ltd of Zhejiang day grass, apple
Fruit polyphenol content >=50%.
Embodiment 1
A kind of pair of liver kidney has the health food of auxiliary protection function, and in parts by weight, raw material includes 200 parts of ganoderma lucidum, peppery
It is 150 parts of wood, 50 parts of cassia seed, 150 parts of Maca, 200 parts of Fructus Corni, 50 parts of cordyceps mycelia powder, 50 parts of whey protein concentrate, big
5-50 parts of beans protein isolate, 0.0001-0.0005 parts of VA, VB10.0005-0.005 parts, VB20.0005-0.005 parts, VB6
0.0005-0.005 parts, 0.1-5 parts of xylo-oligosaccharide, 0.01-0.1 parts of lycopene, 0.01-0.1 parts of apple polyphenol.
Embodiment 2
A kind of pair of liver kidney has the health food of auxiliary protection function, and in parts by weight, raw material includes 10 parts of ganoderma lucidum, Moringa
10 parts, 5 parts of cassia seed, 10 parts of Maca, 10 parts of Fructus Corni, 5 parts of cordyceps mycelia powder, 5 parts of whey protein concentrate, soybean separation protein
White 5 parts, 0.0001 part of VA, VB10.0005 part, VB20.0005 part, VB60.0005 part, 0.1 part of xylo-oligosaccharide, tomato it is red
Plain 0.01,0.01 part of apple polyphenol.
Embodiment 3
A kind of pair of liver kidney has the health food of auxiliary protection function, and in parts by weight, raw material includes 50 parts of ganoderma lucidum, Moringa
20 parts, 10 parts of cassia seed, 20 parts of Maca, 50 parts of Fructus Corni, 10 parts of cordyceps mycelia powder, 10 parts of whey protein concentrate, soybean point
From protein 10 part, 0.0001 part of VA, VB10.001 part, VB20.001 part, VB60.001 part, 1 part of xylo-oligosaccharide, tomato it is red
0.02 part, 0.02 part of apple polyphenol of element.
Embodiment 4
A kind of pair of liver kidney has the health food of auxiliary protection function, and in parts by weight, raw material includes 150 parts of ganoderma lucidum, peppery
It is 100 parts of wood, 40 parts of cassia seed, 100 parts of Maca, 150 parts of Fructus Corni, 40 parts of cordyceps mycelia powder, 40 parts of whey protein concentrate, big
40 parts of beans protein isolate, 0.0005 part of VA, VB1.005 part, VB20.005 part, VB60.005 part, 5 parts of xylo-oligosaccharide, tomato
0.08 part of red pigment, 0.08 part of apple polyphenol.
Embodiment 5
A kind of pair of liver kidney has the health food of auxiliary protection function, and in parts by weight, raw material includes 120 parts of ganoderma lucidum, peppery
Wooden 80 parts, 15 parts of cassia seed, 35 parts of Maca, 70 parts of Fructus Corni, 20 parts of cordyceps mycelia powder, 15 parts of whey protein concentrate, soybean
25 parts of protein isolate, 0.0003 part of VA, VB10.002 part, VB20.003 part, VB60.002 part, 3 parts of xylo-oligosaccharide, tomato
0.05 part of red pigment, 0.03 part of apple polyphenol.
Embodiment 6
A kind of pair of liver kidney has the health food of auxiliary protection function, and in parts by weight, raw material includes 100 parts of ganoderma lucidum, peppery
Wooden 60 parts, 18 parts of cassia seed, 55 parts of Maca, 80 parts of Fructus Corni, 25 parts of cordyceps mycelia powder, 25 parts of whey protein concentrate, soybean
15 parts of protein isolate, 0.0002 part of VA, VB10.003 part, VB20.002 part, VB60.003 part, 2 parts of xylo-oligosaccharide, tomato
0.03 part of red pigment, 0.05 part of apple polyphenol.
Embodiment 7
A kind of pair of liver kidney has the health food of auxiliary protection function, is formulated same as Example 1, the system of the health food
Preparation Method the following steps are included:
1) ingredient；Required raw material is weighed according to the ratio；
2) after mixing ganoderma lucidum, Moringa, cassia seed, Maca, Fructus Corni, 90% alcohol reflux of 5 times of weight is added to extract 3
It is secondary, it 0.5 hour every time, filters, filter residue is spare；Merging filtrate concentrates the filtrate to clear cream (1.30,30 DEG C of relative density),
Ethyl alcohol, which is added, makes alcohol content up to 75%, obtains solution I；
3) water of 5 times of weight is added to decoct 3 times filter residue obtained by step 2), 0.5 hour every time, collecting decoction, filtration will filter
Liquid is concentrated into clear cream (1.30,30 DEG C of relative density), adds ethyl alcohol to make alcohol content up to 75%, obtains solution II；
4) merge the solution I and solution II, stir evenly, stand, it is (relatively close to be concentrated into clear cream for filtration, filtrate recycling ethanol
Degree is 1.30,30 DEG C)；By formula be added remaining raw material (cordyceps mycelia powder, whey protein concentrate, soybean protein isolate, VA,
VB1、VB2、VB6, xylo-oligosaccharide, lycopene, apple polyphenol etc.) active mixture is made；100 parts of the active mixture is taken, is added
Adding 12.5 parts of maltodextrin, 55.5 parts of microcrystalline cellulose, be uniformly mixed, adds ethanol in proper amount solution softwood, 16 meshes are pelletized, and 60
DEG C drying, 12 mesh sieves, that is, granule.
20g/ bags of product specification；It is recommended that eating method and amount: 3 times a day, 1 bag every time, warm boiled water；Shelf-life
24 months；Storage practice room temperature, ventilation, it is dry at.
Embodiment 8
A kind of pair of liver kidney has the health food of auxiliary protection function, is formulated same as Example 2, the system of the health food
Preparation Method the following steps are included:
1) ingredient；Required raw material is weighed according to the ratio；
2) after mixing ganoderma lucidum, Moringa, cassia seed, Maca, Fructus Corni, 50% alcohol reflux of 10 times of weight is added to extract 1
It is secondary, it 3.0 hours every time, filters, filter residue is spare；Merging filtrate concentrates the filtrate to clear cream (1.10,30 DEG C of relative density),
Ethyl alcohol, which is added, makes alcohol content up to 70%, obtains solution I；
3) water of 15 times of weight is added to decoct 1 time filter residue obtained by step 2), 2 hours every time, collecting decoction, filtration will filter
Liquid is concentrated into clear cream (1.10,30 DEG C of relative density), adds ethyl alcohol to make alcohol content up to 70%, obtains solution II；
4) merge the solution I and solution II, stir evenly, stand, it is (relatively close to be concentrated into clear cream for filtration, filtrate recycling ethanol
Degree is 1.10,30 DEG C)；By formula be added remaining raw material (cordyceps mycelia powder, whey protein concentrate, soybean protein isolate, VA,
VB1、VB2、VB6, xylo-oligosaccharide, lycopene, apple polyphenol etc.), active mixture is made；100 parts of the active mixture is taken,
12.5 parts of maltodextrin, 55.5 parts of microcrystalline cellulose to be added, is uniformly mixed, ethanol in proper amount solution softwood is added, 16 meshes are pelletized,
60 DEG C of dryings, 12 mesh sieves, that is, granule.
20g/ bags of product specification；It is recommended that eating method and amount: 3 times a day, 1 bag every time, warm boiled water；Shelf-life
24 months；Storage practice room temperature, ventilation, it is dry at.
Embodiment 9
A kind of pair of liver kidney has the health food of auxiliary protection function, is formulated same as Example 3, the system of the health food
Preparation Method the following steps are included:
1) ingredient；Required raw material is weighed according to the ratio；
2) will ganoderma lucidum, Moringa, cassia seed, Maca, Fructus Corni mix after, with 70% alcohol reflux extract 2 times, the 1st time plus
Enter 8 times of w ethanols and extract 3h, 6 times of w ethanols of the 2nd addition extract 1h, filter, filter residue is spare；Merging filtrate, by filtrate
It is concentrated into clear cream (1.10,30 DEG C of relative density), ethyl alcohol, which is added, makes alcohol content up to 70%, obtains solution I；
3) filter residue obtained by step 2) is added water to cook 2 times, 10 times of weight waters of the 1st addition decoct 2h, the 2nd 8 times of addition
W ethanol extracts 1h, collecting decoction, and filtration concentrates the filtrate to clear cream (1.10,30 DEG C of relative density), ethyl alcohol is added to make to contain
Alcohol amount obtains solution II up to 70%；
4) merge the solution I and solution II, stir evenly, stand, it is (relatively close to be concentrated into clear cream for filtration, filtrate recycling ethanol
Degree is 1.10,30 DEG C)；By formula be added remaining raw material (cordyceps mycelia powder, whey protein concentrate, soybean protein isolate, VA,
VB1、VB2、VB6, xylo-oligosaccharide, lycopene, apple polyphenol etc.), active mixture is made；100 parts of the active mixture is taken,
12.5 parts of maltodextrin, 55.5 parts of microcrystalline cellulose to be added, is uniformly mixed, ethanol in proper amount solution softwood is added, 16 meshes are pelletized,
60 DEG C of dryings, 12 mesh sieves, that is, granule.
20g/ bags of product specification；It is recommended that eating method and amount: 3 times a day, 1 bag every time, warm boiled water；Shelf-life
24 months；Storage practice room temperature, ventilation, it is dry at.
Embodiment 10
A kind of pair of liver kidney has the health food of auxiliary protection function, is formulated same as Example 5, the system of the health food
Preparation Method the following steps are included:
1) ingredient；Required raw material is weighed according to the ratio；
2) will ganoderma lucidum, Moringa, cassia seed, Maca, Fructus Corni mix after, with 75% alcohol reflux extract 2 times, the 1st time plus
Enter 8 times of w ethanols and extract 3h, 6 times of w ethanols of the 2nd addition extract 1h, filter, filter residue is spare；Merging filtrate, by filtrate
It is concentrated into clear cream (1.30,30 DEG C of relative density), ethyl alcohol, which is added, makes alcohol content up to 75%, obtains solution I；
3) filter residue obtained by step 2) is added water to cook 2 times, 10 times of weight waters of the 1st addition decoct 2h, the 2nd 8 times of addition
W ethanol extracts 1h, collecting decoction, and filtration concentrates the filtrate to clear cream (1.30,30 DEG C of relative density), ethyl alcohol is added to make to contain
Alcohol amount obtains solution II up to 75%；
4) merge the solution I and solution II, stir evenly, stand, it is (relatively close to be concentrated into clear cream for filtration, filtrate recycling ethanol
Degree is 1.30,30 DEG C)；By formula be added remaining raw material (cordyceps mycelia powder, whey protein concentrate, soybean protein isolate, VA,
VB1、VB2、VB6, xylo-oligosaccharide, lycopene, apple polyphenol etc.), active mixture is made；100 parts of the active mixture is taken,
12.5 parts of maltodextrin, 55.5 parts of microcrystalline cellulose to be added, is uniformly mixed, ethanol in proper amount solution softwood is added, 16 meshes are pelletized,
60 DEG C of dryings, 12 mesh sieves, that is, granule.
20g/ bags of product specification；It is recommended that eating method and amount: 3 times a day, 1 bag every time, warm boiled water；Shelf-life
24 months；Storage practice room temperature, ventilation, it is dry at.
Embodiment 11
A kind of pair of liver kidney has the health food of auxiliary protection function, is formulated same as Example 4, the system of the health food
Preparation Method is the same as embodiment 9.
20g/ bags of product specification；It is recommended that eating method and amount: 3 times a day, 1 bag every time, warm boiled water；Shelf-life
24 months；Storage practice room temperature, ventilation, it is dry at.
Embodiment 12
A kind of pair of liver kidney has the health food of auxiliary protection function, and formula is same as Example 6, to make according to a conventional method
At packed medicinal tea.
Embodiment 13
A kind of pair of liver kidney has the health food of auxiliary protection function, and formula is same as Example 2, to make according to a conventional method
At capsule.
Embodiment 14
A kind of pair of liver kidney has the health food of auxiliary protection function, and formula is same as Example 3, and preparation method includes
Obtained active mixture is first made as described in Example 8；Tablet is made in conventional method again.
Embodiment 15
A kind of pair of liver kidney has the health food of auxiliary protection function, and formula is same as Example 4, and preparation method includes
Obtained active mixture is first made as described in Example 9；Capsule is made in conventional method again.
Embodiment 16
A kind of pair of liver kidney has the health food of auxiliary protection function, and formula is same as Example 5, and preparation method includes
Obtained active mixture is first made as described in Example 8；Tablet is made in conventional method again.
Comparative example 1
A kind of Chinese herbal granules, its raw material only includes 120 parts of ganoderma lucidum, 80 parts of Moringa, 15 parts of cassia seed in parts by weight；Its
Preparation method include first by ganoderma lucidum, Moringa, cassia seed as described in Example 10 be made clear cream (i.e. step 4) clear cream, it is relatively close
Degree is 1.30,30 DEG C)；100 parts of the clear cream is taken, 12.5 parts of maltodextrin, 55.5 parts of microcrystalline cellulose are added, is uniformly mixed, adds
Ethanol in proper amount solution softwood, the granulation of 16 meshes, 60 DEG C of dryings, 12 mesh sieves, that is, granule.
Comparative example 2
A kind of Chinese herbal granules, its raw material only includes 35 parts of Maca, 70 parts of Fructus Corni, cordyceps mycelia powder in parts by weight
20 parts, 15 parts of whey protein concentrate, 25 parts of soybean protein isolate；Preparation method includes that Maca, Fructus Corni are first pressed embodiment
Clear cream (i.e. step 4) clear cream, 1.30,30 DEG C of relative density) is made in 10 method；Again by formula be added cordyceps mycelia powder,
Active mixture is made in whey protein concentrate, soybean protein isolate；100 parts of active mixture are taken, maltodextrin 12.5 is added
Part, 55.5 parts of microcrystalline cellulose are uniformly mixed, and add ethanol in proper amount solution softwood, the granulation of 16 meshes, 60 DEG C of dryings, 12 meshes
Whole grain, that is, granule.
Comparative example 3
A kind of Chinese herbal granules, in parts by weight its raw material include 20 parts of cordyceps mycelia powder, 15 parts of whey protein concentrate,
25 parts of soybean protein isolate, 3 parts of xylo-oligosaccharide, 0.05 part of lycopene, 0.03 part of apple polyphenol.Preparation method includes first will
Cordyceps mycelia powder, whey protein concentrate, soybean protein isolate, xylo-oligosaccharide, lycopene, apple polyphenol are uniformly mixed, system
Obtain active mixture；100 parts of active mixture are taken, 12.5 parts of maltodextrin, 55.5 parts of microcrystalline cellulose are added, is uniformly mixed,
Add ethanol in proper amount solution softwood, the granulation of 16 meshes, 60 DEG C of dryings, 12 mesh sieves, that is, granule.
Experimental example 1 has auxiliary protection function zoopery to chemical damage
Experimental method: there is auxiliary guarantor to chemical lesion according in " health food is examined and assessment technique specification -2003 "
Experiment on Function method is protected, using alcoholic hepatic injury model scheme.Laboratory sample: health food granule prepared by embodiment 10,
Control sample: the Chinese herbal granules of comparative example 1-3 preparation.It is every for pressing human body to recommend dosage by laboratory sample and control sample respectively
3 times a day, each 20g is converted to 1g/kgBW by 60kg weight to people (adult).Separately set an alcoholic hepatic injury model group (mould
Type control group) and a negative control group.Every group of 12 animals (male white rat).
Experimental result:
1. influence of the sample to rat body weight: each group rat body weight is consistent before testing, the weight of each all rats of test process
And gain in weight when off-test is compared to each other, difference without conspicuousness (P > 0.05), shows the sample to the weight of rat
Increase satisfaction and significantly affects effect.
2. sample is to the shadow of hepatic tissue lipid peroxidation catabolite malonaldehyde (MDA) content of alcoholic liver injury in rats
Ring: the Liver MDA of liver injury model control rats is aobvious to be higher than negative control group, and the difference of the two is with extremely significant
Property (P < 0.01), illustrate liver injury model set up.The Liver MDA of control group (control sample 1-3, similarly hereinafter) rat is equal
Lower than liver injury model control group, but there are no significant (P > 0.05) for each group and the difference of liver injury model control group, shows this
The lipid peroxide content in liver tissues of rats that sample damages Alcoholic has certain reduction effect, but is not apparent.
The Liver MDA of experimental group (health food granule prepared by embodiment 10, similarly hereinafter) rat is substantially less than hepatic injury mould
It is aobvious to show that the lipid peroxide content in liver tissues of rats that the sample damages Alcoholic has for type control group (P < 0.05)
Write reduction effect.
Influence of 3 samples to hepatic tissue triglycerides (TG) content of alcoholic hepatic injury rat:
The hepatic tissue TG content of liver injury model control rats is apparently higher than negative control, and the difference of the two has extremely aobvious
Work property (P < 0.01), illustrates that hepatic injury is obviously set up.The hepatic tissue TG content of control group 1-3 rat is below liver injury model
Control group, but there are no significant (P > 0.05) for each group and the difference of liver injury model control group, shows that the sample damages Alcoholic
Lipid peroxide content in the liver tissues of rats of wound has certain reduction effect, but is not apparent.The liver of experimental group rat
Tissue T G content is substantially less than liver injury model control group, and difference all has extremely significant property (P < 0.01), illustrates that the sample has
Reduce the effect of hepatic tissue triglycerides (TG) content of the rat of Alcoholic damage.
The influence of hepatic tissue Reductive glutathione (GSH) content for the rat that 4 samples damage Alcoholic:
The hepatic tissue GSH content of liver injury model control rats is significantly lower than negative control group, and the difference of the two has pole
Conspicuousness (P < 0.01) shows that liver injury model is set up.The hepatic tissue GSH content of control group 1-3 rat is obviously higher than model
Control group, there are no significant for single difference (P > 0.05), shows that the GSH in liver tissues of rats that the sample damages Alcoholic contains
The measurer effect of improving, but be not apparent.The difference of experimental group and model control group all has extremely significant property (P <
0.01), show that the sample has the function of improving GSH content in the liver tissues of rats of alcoholic liver injury.
Influence of 5 samples to the hepatic tissue steatosis of alcoholic liver injury in rats: the liver of liver damage model control group rat
Tissue fat denaturation score value is significantly higher than negative control group, and the difference of the two has extremely significant property (P < 0.01), shows that liver damages
Model is set up.The hepatic tissue Steatosis score value of control group 1-3 rat is below liver injury model control group, but each group and liver
There are no significant for the difference of damage model control group (P > 0.05), shows in liver tissues of rats that the sample damages Alcoholic
Steatosis has certain mitigation effect, but is not apparent.The hepatic tissue Steatosis score value of experimental group rat is lower than liver
Model control group is damaged, and the difference of each dosage group and model control group all has extremely significant property (P < 0.01), shows that the sample has
Play the role of mitigating the liver tissues of rats steatosis of alcoholic liver injury.
6 brief summaries: health food granule prepared by the embodiment of the present invention 10 can reduce alcoholic liver injury rat model
Triglycerides (TG) content in hepatic tissue, improves Reductive glutathione (GSH) content in its hepatic tissue, mitigates its hepatic tissue
Steatosis degree, the weight of rat is had no significant effect.It can be seen that the sample, which has, has auxiliary to alcoholic liver injury
Defencive function.
2 toxicity test of experimental example
Laboratory sample: health food granule prepared by embodiment 10, recommending dosage by human body is everyone (adult) daily 3
Secondary, each 20g is converted to 1g/kgBW by 60kg weight.
Experimental method: safety is carried out according to " health food is examined and assessment technique specification " (version in 2003) pertinent regulations
Toxicological evaluation, as a result as follows:
1. acute toxicity test: showing to belong to non-poisonous material to the acute oral experiment of female, male mouse.
2. three genetic toxicity tests: three genetic toxicity tests (Salmonella reversion tests, mouse bone marrow polychromatic erythrocytes micronucleus
Test, mouse inbred strain) result is feminine gender.
During 3.30 days feeding trials, each dosage group rat body weight increases, food utilization is compared with the control group without significant
Sex differernce (P > 0.05).Female, male mouse blood biochemistry index, routine blood indexes and liver/body, spleen/body, kidney/body, male mouse testis/body ratio
There are no significant (P > 0.05) for difference compared with the control group.Liver,spleen,kidney, Stomach duodenum, the inspection of testis (ovary) histopathology
It looks into without obvious damage.
The experiment of 3 human experiment of experimental example
Select 31 age 45 years old~68 years old male alcohol hepatopaths, average age 55.3 years old, without other serious diseases.
Selection alcoholic liver patient criteria: patient has long-term, heavy drinking history, 40 ° daily 2 liang of white wine or more, lasts 3 years or more；
Loss of appetite, fatigue and weak, lean body mass；There is slight or moderate liver fibrosis；Serum glutamic oxalacetic transaminase significantly increases, and paddy third
Transaminase is normal, ratio between two 2: 1~5: 1.
Efficacy determination: effective: to stop excessive drinking；Symptom disappearance-appetite is good, and fatigue and weak disappears, with it energetically；It is thin
Improve, physical comfort；Liver fibrosis checks that 4 indexs are all qualified；Glutamic-oxalacetic transaminease is remarkably decreased, the ratio between with glutamic-pyruvic transaminase
< 2: 1.Effective: excessive drinking is reduced, and loss of appetite, fatigue and weak, lean body mass are alleviated；Grass Valley transaminase decline 10% with
On, but not up to effective standard.It is invalid: to continue to indulge in excessive drinking, symptom is unchanged.
When test-meal is tested, withdraw other medicines and nutrient and healthcare products, takes the health food of the preparation of the embodiment of the present invention 10
Granule, 3 times a day, each 20g, warm boiled water after meal；Observation 6 months are 1 period.Symptom has alleviation after 2 months,
After taking 6 months, symptom is relieved.In 31 people of clinical trial, effective 12 people, effective 15 people, invalid 4 people, total effective rate
87.1%.
The dosage form that granule is taken in this experimental example keeps drug administration simple and easy, effectively raises the absorption of drug
And utilize, in addition, what the present invention took is pure natural medical, any toxic additive and addictive drug are not added, it will not
Appetite-suppressing not will lead to diarrhea, have no toxic side effect, not habituation.It also found when experiment, the weight of most of experimental group subject
Mitigated, and blood lipid, blood pressure have different degrees of reduction, digestion has improvement, and mental attitude significantly improves, and prompts the present invention also
With health-care effects such as reducing blood lipid, blood pressure lowering and weight-reducing.
Although above the present invention is described in detail with a general description of the specific embodiments,
On the basis of the present invention, it can be made some modifications or improvements, this will be apparent to those skilled in the art.Cause
This, these modifications or improvements, fall within the scope of the claimed invention without departing from theon the basis of the spirit of the present invention.
Claims (9)
1. the health food that a kind of pair of liver kidney has auxiliary protection function, which is characterized in that its raw material includes ganoderma lucidum in parts by weight
10-200 parts, 10-150 parts of Moringa, 5-50 parts of cassia seed, Maca 10-150 parts, 10-200 parts of Fructus Corni, cordyceps mycelia powder 5-
50 parts, 5-50 parts of whey protein concentrate, 5-50 parts of soybean protein isolate, 0.0001-0.0005 parts of VA, VB1 0.0005-
0.005 part, VB20.0005-0.005 parts, VB60.0005-0.005 parts, 0.1-5 parts of xylo-oligosaccharide, lycopene 0.01-0.1
Part, 0.01-0.1 parts of apple polyphenol；
The health food is prepared by method comprising the following steps:
1) ingredient；
2) after mixing ganoderma lucidum, Moringa, cassia seed, Maca, Fructus Corni, the 50%-90% alcohol reflux of 5-10 times of weight is added to mention
It takes 1-3 times, 0.5-3.0 hours each, filtration, filter residue is spare；Merging filtrate concentrates the filtrate to clear cream, and ethyl alcohol, which is added, to be made to contain
Alcohol amount reaches 70%-75%, obtains solution I；
3) water of 5-15 times of weight is added to decoct 1-3 times filter residue obtained by step 2), 0.5-2 hours each, collecting decoction, filtration,
Clear cream is concentrated the filtrate to, adds ethyl alcohol to make alcohol content up to 70%-75%, obtains solution II；
4) merge the solution I and solution II, stir evenly, stand, filtration, filtrate recycling ethanol is concentrated into clear cream；It is added by formula
Suitable dosage form is made in remaining raw material and appropriate amount of auxiliary materials.
2. health food according to claim 1, which is characterized in that its raw material includes ganoderma lucidum 50-150 in parts by weight
Part, 20-100 parts of Moringa, 10-40 parts of cassia seed, Maca 20-100 parts, 50-150 parts of Fructus Corni, cordyceps mycelia powder 10-40
Part, 10-40 parts of whey protein concentrate, 10-40 parts of soybean protein isolate, 0.0001-0.0005 parts of VA, VB1 0.001-0.005
Part, VB20.001-0.005 parts, VB60.001-0.005 parts, 1-5 parts of xylo-oligosaccharide, 0.02-0.08 parts of lycopene, apple
0.02-0.08 parts of polyphenol.
3. health food according to claim 1, which is characterized in that in parts by weight its raw material include 120 parts of ganoderma lucidum, it is peppery
Wooden 80 parts, 15 parts of cassia seed, 35 parts of Maca, 70 parts of Fructus Corni, 20 parts of cordyceps mycelia powder, 15 parts of whey protein concentrate, soybean
25 parts of protein isolate, 0.0003 part of VA, VB10.002 part, VB20.003 part, VB60.002 part, 3 parts of xylo-oligosaccharide, tomato
0.05 part of red pigment, 0.03 part of apple polyphenol.
4. health food according to claim 1-3, which is characterized in that its raw material or auxiliary material further include pharmaceutically
Or acceptable carrier on food or on health food.
5. health food according to claim 1-3, which is characterized in that the health food is formed into oral system
Agent；It include: capsule, granule, tablet, packed medicinal tea, pulvis.
6. health food according to claim 1-3, which is characterized in that its raw material of the health food or auxiliary material
It further include microcrystalline cellulose, magnesium stearate.
7. the preparation method of any one of the claim 1-6 health food, which comprises the following steps:
1) ingredient；
2) after mixing ganoderma lucidum, Moringa, cassia seed, Maca, Fructus Corni, the 50%-90% alcohol reflux of 5-10 times of weight is added to mention
It takes 1-3 times, 0.5-3.0 hours each, filtration, filter residue is spare；Merging filtrate concentrates the filtrate to clear cream, and ethyl alcohol, which is added, to be made to contain
Alcohol amount reaches 70%-75%, obtains solution I；
3) water of 5-15 times of weight is added to decoct 1-3 times filter residue obtained by step 2), 0.5-2 hours each, collecting decoction, filtration,
Clear cream is concentrated the filtrate to, adds ethyl alcohol to make alcohol content up to 70%-75%, obtains solution II；
4) merge the solution I and solution II, stir evenly, stand, filtration, filtrate recycling ethanol is concentrated into clear cream；It is added by formula
Suitable dosage form is made in remaining raw material and appropriate amount of auxiliary materials.
8. the preparation method of health food according to claim 7, which is characterized in that appropriate microcrystalline cellulose is added in step 4)
Element, magnesium stearate, are made granule.
9. the preparation method of health food according to claim 7, which comprises the following steps:
1) ingredient；
2) will ganoderma lucidum, Moringa, cassia seed, Maca, Fructus Corni mix after, with 70%-75% alcohol reflux extract 2 times, the 1st time plus
Enter 8 times of w ethanols and extract 3h, 6 times of w ethanols of the 2nd addition extract 1h, filter, filter residue is spare；Merging filtrate, by filtrate
It is concentrated into clear cream, ethyl alcohol, which is added, makes alcohol content up to 70%-75%, obtains solution I；
3) filter residue obtained by step 2) is added water to cook 2 times, 10 times of weight waters of the 1st addition decoct 2h, 8 times of weight of the 2nd addition
Ethyl alcohol extracts 1h, collecting decoction, and filtration concentrates the filtrate to clear cream, adds ethyl alcohol to make alcohol content up to 70%-75%, obtains solution II；
4) merge the solution I and solution II, stir evenly, stand, filtration, filtrate recycling ethanol is concentrated into clear cream；It is added by formula
Remaining raw material is added and suitable dosage form is made in appropriate amount of auxiliary materials.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610068849.1A CN105597083B (en) | 2016-02-01 | 2016-02-01 | A kind of pair of liver kidney has health food of auxiliary protection function and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610068849.1A CN105597083B (en) | 2016-02-01 | 2016-02-01 | A kind of pair of liver kidney has health food of auxiliary protection function and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105597083A CN105597083A (en) | 2016-05-25 |
| CN105597083B true CN105597083B (en) | 2019-02-01 |
Family
ID=55977789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610068849.1A Active CN105597083B (en) | 2016-02-01 | 2016-02-01 | A kind of pair of liver kidney has health food of auxiliary protection function and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105597083B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108056465A (en) * | 2017-12-29 | 2018-05-22 | 贺州市星辉科技有限公司 | A kind of antifatigue chewable tablets and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102742840A (en) * | 2012-07-16 | 2012-10-24 | 西藏然康科技有限公司 | Maca Cordyceps buccal tablet and preparation method thereof |
| CN104547546A (en) * | 2014-12-26 | 2015-04-29 | 扬子江药业集团四川海蓉药业有限公司 | Traditional Chinese medicinal composition for reinforcing kidney and moistening lung and preparation method of traditional Chinese medicinal composition in different dosage forms |
| CN105146542A (en) * | 2015-10-25 | 2015-12-16 | 林爱玉 | Health-care food with antioxidant function and preparation method thereof |
| CN105267695A (en) * | 2015-11-17 | 2016-01-27 | 安徽千方生物科技有限公司 | Ganoderma lucidum spore powder compound product for improving anti-tumor curative effects and method for preparing ganoderma lucidum spore powder compound product |
-
2016
- 2016-02-01 CN CN201610068849.1A patent/CN105597083B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102742840A (en) * | 2012-07-16 | 2012-10-24 | 西藏然康科技有限公司 | Maca Cordyceps buccal tablet and preparation method thereof |
| CN104547546A (en) * | 2014-12-26 | 2015-04-29 | 扬子江药业集团四川海蓉药业有限公司 | Traditional Chinese medicinal composition for reinforcing kidney and moistening lung and preparation method of traditional Chinese medicinal composition in different dosage forms |
| CN105146542A (en) * | 2015-10-25 | 2015-12-16 | 林爱玉 | Health-care food with antioxidant function and preparation method thereof |
| CN105267695A (en) * | 2015-11-17 | 2016-01-27 | 安徽千方生物科技有限公司 | Ganoderma lucidum spore powder compound product for improving anti-tumor curative effects and method for preparing ganoderma lucidum spore powder compound product |
Non-Patent Citations (1)
| Title |
|---|
| 番茄红素和维生素C对慢性酒精中毒小鼠肝脏的保护作用;杨春等;《现代预防医学》;20151231;第42卷(第17期);第3204-3207页 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105597083A (en) | 2016-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101106499B1 (en) | Food composition with hepatoprotective effect containing the peduncle extracts of Hovenia dulcis Thunb | |
| KR20200120465A (en) | Composition for preventing or treating liver damage by alcohol which is excellent in hangover resolution | |
| KR20150040392A (en) | undiluted stevia liquid and the berages, and its manufacturing method | |
| CN105770420A (en) | Chinese herbal medicine with anti-cancer effect and preparation method thereof | |
| CN106722437A (en) | One kind is for liver-protective containing selenium product and its preparation method and application | |
| CN104352542A (en) | Sea cucumber and saussurea involucrata composition preparation and preparation method thereof | |
| CN108066384A (en) | A kind of Chinese medicine preparation with strengthen immunity and preparation method thereof | |
| CN104739964B (en) | A kind of snail sobering preparation and preparation method thereof | |
| CN105597083B (en) | A kind of pair of liver kidney has health food of auxiliary protection function and preparation method thereof | |
| CN103977390B (en) | A kind of preparation method and its usage of ginger onion medicated wine composition | |
| CN105685994A (en) | Healthcare food capable of assisting in blood lipid reduction and preparation method and application of healthcare food capable of assisting in blood lipid reduction | |
| CN109527577A (en) | A kind of composition with sobering up and liver protecting functions | |
| CN105709210A (en) | Health food with liver protection function | |
| KR20100133079A (en) | Herbal extracts composition for the prevention of alcoholic fatty liver, hyperlipidemia and hangover | |
| CN108420890A (en) | A kind of composition and preparation method thereof with effect for reducing blood fat | |
| CN101336719B (en) | Nutrient powder capable of expelling toxin and preventing cancer | |
| CN107115478A (en) | A kind of Chinese medicine composition, its preparation method and application for treating insomnia | |
| KR20160086457A (en) | Composition comprising alcohol extract of GamiBangkeehwangkeetang for preventing and treating a rheumatoid arthritis | |
| KR100642801B1 (en) | Anti-diabetic food composition comprising extracts from natural herbal materials and pear and process for preparing the same | |
| CN110025011A (en) | A kind of Radix Ophiopogonis ginseng lozenge of strengthen immunity | |
| CN104206597B (en) | A kind of schisandra health care tea alleviating YIN-deficiency of the lung and kidney symptom and preparation method thereof | |
| CN108478701A (en) | A kind of lozenge of strengthen immunity | |
| Gryszkin et al. | Ganotherapy in sports | |
| CN102579713B (en) | Traditional Chinese medicine for treating children obesity and preparation method | |
| CN114425066B (en) | Composition, medicine, food or health care product for relieving physical fatigue and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |